{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:18:11Z","timestamp":1794860291036,"version":"4.9.1"},"reference-count":40,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National Institute on Aging and the National Institute of Neurological Diseases and Stroke","award":["U01 AG045390"],"award-info":[{"award-number":["U01 AG045390"]}]},{"name":"National Institute on Aging and the National Institute of Neurological Diseases and Stroke","award":["U19 AG063911"],"award-info":[{"award-number":["U19 AG063911"]}]},{"name":"National Institute of Neurological Diseases and Stroke and National Center for Advancing Translational Sciences","award":["U54 NS092089"],"award-info":[{"award-number":["U54 NS092089"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Measuring systemic inflammatory markers may improve clinical prognosis and help identify targetable pathways for treatment in patients with autosomal dominant forms of frontotemporal lobar degeneration (FTLD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We measured plasma concentrations of IL-6, TNF\u03b1 and YKL-40 in pathogenic variant carriers (\n                      <jats:italic>MAPT, C9orf72, GRN<\/jats:italic>\n                      ) and non-carrier family members enrolled in the ARTFL-LEFFTDS Longitudinal Frontotemporal Lobar Degeneration consortium. We evaluated associations between baseline plasma inflammation and rate of clinical and neuroimaging changes (linear mixed effects models with standardised (z) outcomes). We compared inflammation between asymptomatic carriers who remained clinically normal (\u2018asymptomatic non-converters\u2019) and those who became symptomatic (\u2018asymptomatic converters\u2019) using area under the curve analyses. Discrimination accuracy was compared with that of plasma neurofilament light chain (NfL).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We studied 394 participants (non-carriers=143,\n                      <jats:italic>C9orf72<\/jats:italic>\n                      =117,\n                      <jats:italic>GRN<\/jats:italic>\n                      =62,\n                      <jats:italic>MAPT<\/jats:italic>\n                      =72). In\n                      <jats:italic>MAPT<\/jats:italic>\n                      , higher TNF\u03b1 was associated with faster functional decline (B=0.12 (0.02, 0.22), p=0.02) and temporal lobe atrophy. In\n                      <jats:italic>C9orf72,<\/jats:italic>\n                      higher TNF\u03b1 was associated with faster functional decline (B=0.09 (0.03, 0.16), p=0.006) and cognitive decline (B=\u22120.16 (\u22120.22, \u22120.10), p&lt;0.001), while higher IL-6 was associated with faster functional decline (B=0.12 (0.03, 0.21), p=0.01). TNF\u03b1 was higher in asymptomatic converters than non-converters (\u03b2=0.29 (0.09, 0.48), p=0.004) and improved discriminability compared with plasma NfL alone (\u0394R\n                      <jats:sup>2<\/jats:sup>\n                      =0.16, p=0.007; NfL: OR=1.4 (1.03, 1.9), p=0.03; TNF\u03b1: OR=7.7 (1.7, 31.7), p=0.007).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Systemic proinflammatory protein measurement, particularly TNF\u03b1, may improve clinical prognosis in autosomal dominant FTLD pathogenic variant carriers who are not yet exhibiting severe impairment. Integrating TNF\u03b1 with markers of neuronal dysfunction like NfL could optimise detection of impending symptom conversion in asymptomatic pathogenic variant carriers and may help personalise therapeutic approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2022-330866","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T13:38:10Z","timestamp":1680010690000},"page":"541-549","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":22,"title":["Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration"],"prefix":"10.1136","volume":"94","clinical-trial-number":[{"clinical-trial-number":"nct04363684","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8419-142X","authenticated-orcid":false,"given":"Breton M","family":"Asken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Ljubenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M","family":"Staffaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin B","family":"Casaletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawren","family":"Vandevrede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Cobigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C","family":"Rojas-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine P","family":"Rankin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kornak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Heuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Shigenaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian S","family":"Appleby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea C","family":"Bozoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiko","family":"Domoto-Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6680-6731","authenticated-orcid":false,"given":"Nupur","family":"Ghoshal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Huey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3485-3445","authenticated-orcid":false,"given":"Irene","family":"Litvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C","family":"Masdeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario F","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belen","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pressman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmela","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Kremers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah K","family":"Forsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad F","family":"Boeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L","family":"Boxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howie J","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel H","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"2023100118500600000_94.7.541.1","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(15)00461-4","article-title":"Frontotemporal dementia","volume":"386","author":"Bang","year":"2015","journal-title":"The Lancet"},{"key":"2023100118500600000_94.7.541.2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181bf997a"},{"key":"2023100118500600000_94.7.541.3","doi-asserted-by":"crossref","unstructured":"Olszewska DA , Lonergan R , Fallon EM , et al . Genetics of frontotemporal dementia. Curr Neurol Neurosci Rep 2016;16. doi:10.1007\/s11910-016-0707-9","DOI":"10.1007\/s11910-016-0707-9"},{"key":"2023100118500600000_94.7.541.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2015.07.019"},{"key":"2023100118500600000_94.7.541.5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI90607"},{"key":"2023100118500600000_94.7.541.6","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3389\/fnins.2019.01298","article-title":"Mechanisms of immune activation by c9orf72-expansions in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"13","author":"Trageser","year":"2019","journal-title":"Front Neurosci"},{"key":"2023100118500600000_94.7.541.7","doi-asserted-by":"publisher","DOI":"10.2174\/156652411795243450"},{"key":"2023100118500600000_94.7.541.8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jnc.13972","article-title":"Monocytes, microglia, and CD200-CD200R1 signaling are essential in the transmission of inflammation from the periphery to the central nervous system","volume":"141","author":"Xie","year":"2017","journal-title":"J Neurochem"},{"key":"2023100118500600000_94.7.541.9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3389\/fneur.2019.01004","article-title":"Peripheral innate immune activation correlates with disease severity in GRN haploinsufficiency","volume":"10","author":"Ljubenkov","year":"2019","journal-title":"Front Neurol"},{"key":"2023100118500600000_94.7.541.10","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-304644"},{"key":"2023100118500600000_94.7.541.11","doi-asserted-by":"crossref","unstructured":"Miller ZA , Sturm VE , Camsari GB , et al . Increased prevalence of autoimmune disease within C9 and FTD\/MND cohorts: completing the picture. Neurol Neuroimmunol Neuroinflamm 2016;3:e301. doi:10.1212\/NXI.0000000000000301","DOI":"10.1212\/NXI.0000000000000301"},{"key":"2023100118500600000_94.7.541.12","doi-asserted-by":"crossref","first-page":"e2296","DOI":"10.1212\/WNL.0000000000011848","article-title":"Plasma neurofilament light for prediction of disease progression in familial frontotemporal lobar degeneration","volume":"96","author":"Rojas","year":"2021","journal-title":"Neurology"},{"key":"2023100118500600000_94.7.541.13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/acn3.290","article-title":"Plasma neurofilament light chain predicts progression in progressive supranuclear palsy","volume":"3","author":"Rojas","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"2023100118500600000_94.7.541.14","doi-asserted-by":"crossref","unstructured":"Ntymenou S , Tsantzali I , Kalamatianos T , et al . Blood biomarkers in frontotemporal dementia: review and meta-analysis. Brain Sci 2021;11:244. doi:10.3390\/brainsci11020244","DOI":"10.3390\/brainsci11020244"},{"key":"2023100118500600000_94.7.541.15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-321954"},{"key":"2023100118500600000_94.7.541.16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/alz.12011","article-title":"Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases","volume":"16","author":"Ramos","year":"2020","journal-title":"Alzheimers Dement"},{"key":"2023100118500600000_94.7.541.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2010.12.006"},{"key":"2023100118500600000_94.7.541.18","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12033"},{"key":"2023100118500600000_94.7.541.19","doi-asserted-by":"publisher","DOI":"10.1037\/0022-3514.46.6.1349"},{"key":"2023100118500600000_94.7.541.20","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/alz.12214","article-title":"Development and validation of the uniform data set (v3.0) executive function composite score (UDS3-EF)","volume":"17","author":"Staffaroni","year":"2021","journal-title":"Alzheimers Dement"},{"key":"2023100118500600000_94.7.541.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2019.06.4947"},{"key":"2023100118500600000_94.7.541.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2011.09.015"},{"key":"2023100118500600000_94.7.541.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2008.03.061"},{"key":"2023100118500600000_94.7.541.24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroimage.2015.06.094","article-title":"Estimating anatomical trajectories with bayesian mixed-effects modeling","volume":"121","author":"Ziegler","year":"2015","journal-title":"Neuroimage"},{"key":"2023100118500600000_94.7.541.25","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy319"},{"key":"2023100118500600000_94.7.541.26","doi-asserted-by":"crossref","unstructured":"Staffaroni AM , Goh S-Y , Cobigo Y , et al . Rates of brain atrophy across disease stages in familial frontotemporal dementia associated with MAPT, GRN, and c9orf72 pathogenic variants. JAMA Netw Open 2020;3. doi:10.1001\/jamanetworkopen.2020.22847","DOI":"10.1001\/jamanetworkopen.2020.22847"},{"key":"2023100118500600000_94.7.541.27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jneuroim.2018.05.011","article-title":"Prevalence of immunological diseases in a finnish frontotemporal lobar degeneration cohort with the c9orf72 repeat expansion carriers and non-carriers","volume":"321","author":"Katisko","year":"2018","journal-title":"J Neuroimmunol"},{"key":"2023100118500600000_94.7.541.28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00415-019-09552-1","article-title":"Peripheral inflammatory markers and clinical correlations in patients with frontotemporal lobar degeneration with and without the C9orf72 repeat expansion","volume":"267","author":"Katisko","year":"2020","journal-title":"J Neurol"},{"key":"2023100118500600000_94.7.541.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2019.04.007"},{"key":"2023100118500600000_94.7.541.30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JAD-170602","article-title":"Cerebrospinal fluid and plasma levels of inflammation differentially relate to CNS markers of Alzheimer\u2019s disease pathology and neuronal damage","volume":"62","author":"Bettcher","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"2023100118500600000_94.7.541.31","doi-asserted-by":"crossref","unstructured":"Mammana S , Fagone P , Cavalli E , et al . The role of macrophages in neuroinflammatory and neurodegenerative pathways of Alzheimer\u2019s disease, amyotrophic lateral sclerosis, and multiple sclerosis: pathogenetic cellular effectors and potential therapeutic targets. Int J Mol Sci 2018;19:831. doi:10.3390\/ijms19030831","DOI":"10.3390\/ijms19030831"},{"key":"2023100118500600000_94.7.541.32","doi-asserted-by":"publisher","DOI":"10.1159\/000322228"},{"key":"2023100118500600000_94.7.541.33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12974-021-02332-7","article-title":"Biologic TNF-\u03b1 inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy","volume":"18","author":"Ou","year":"2021","journal-title":"J Neuroinflammation"},{"key":"2023100118500600000_94.7.541.34","doi-asserted-by":"crossref","unstructured":"Staffaroni AM , Weintraub S , Rascovsky K , et al . Uniform data set language measures for bvFTD and ppa diagnosis and monitoring. Alzheimers Dement (Amst) 2021;13:e12148. doi:10.1002\/dad2.12148","DOI":"10.1002\/dad2.12148"},{"key":"2023100118500600000_94.7.541.35","doi-asserted-by":"crossref","first-page":"e2384","DOI":"10.1212\/WNL.0000000000009451","article-title":"Revised self-monitoring scale: a potential endpoint for frontotemporal dementia clinical trials","volume":"94","author":"Toller","year":"2020","journal-title":"Neurology"},{"key":"2023100118500600000_94.7.541.36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cytogfr.2019.01.002","article-title":"Progranulin: a conductor of receptors orchestra, a chaperone of lysosomal enzymes and a therapeutic target for multiple diseases","volume":"45","author":"Cui","year":"2019","journal-title":"Cytokine Growth Factor Rev"},{"key":"2023100118500600000_94.7.541.37","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R112.399170"},{"key":"2023100118500600000_94.7.541.38","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr179"},{"key":"2023100118500600000_94.7.541.39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/alz.12001","article-title":"Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration","volume":"16","author":"Casaletto","year":"2020","journal-title":"Alzheimers Dement"},{"key":"2023100118500600000_94.7.541.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2288-7"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2022-330866","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T21:52:03Z","timestamp":1696197123000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2022-330866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,6,14]]},"published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1136\/jnnp-2022-330866"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2022-330866","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]}}}